NTK Institute Logo Mission Statement - Dedicated to improving medical practice through the immediate delivery of new clinically-relevant science to physicians who most urgently need to know about this science Need-To-Know Science Scoring System
About The Institute
NTK Initiative
NTK Watch
Recently Scored Science
Contact Us
To sign up to receive the NTK Watch daily e-mail
All alendronate News
05/24/2016 Male osteoporosis (Z Rheumatol)
05/17/2016 Oral Bisphosphonates and Risk of Wet Age-Related Macular Degeneration (Am J Ophthalmol)
04/06/2016 Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome (Rheumatol Int)
03/31/2016 Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen (Breast Cancer Res Treat)
03/24/2016 Treatment for osteoporosis in people with -thalassaemia (Cochrane Database Syst Rev)
02/29/2016 Incidence of Atypical Femur Fractures in Cancer Patients: The MD Anderson Cancer Center Experience (J Bone Miner Res)
02/19/2016 Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report (BMC Musculoskel Disord)
01/25/2016 Urine Calcium and Bone Mineral Density in Calcium Stone-Forming Patients Treated with Alendronate and Hydrochlorothiazide (Urol Int)
01/22/2016 Postmenopausal Osteoporosis (N Engl J Med)
01/08/2016 Teriparatide Versus Alendronate for the Preservation of Bone Mineral Density After Total Hip Arthroplasty - A randomized Controlled Trial (J Arthroplasty)
12/30/2015 Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study (Osteoporos Int)
12/20/2015 Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday (Osteoporos Int)
12/20/2015 Documentation of renal glomerular and tubular impairment and glomerular hyperfiltration in multitransfused patients with beta thalassemia (Ann Hematol)
12/18/2015 An effect comparison of teriparatide and bisphosphonate on posterior lumbar interbody fusion in patients with osteoporosis: a prospective cohort study and preliminary data (Eur Spine J)
12/17/2015 Efficacy and safety of pamidronate in children with vitamin D intoxication (Pediatr Int)
12/10/2015 Bisphosphonate drug holidays - when, why and for how long? (Climacteric)
11/26/2015 A comparison of the intrasubject variation of drug exposure between generic and brand-name drugs: a retrospective analysis of replicate design trials (Br J Clin Pharmacol)
11/18/2015 Bilateral distal fibula fractures in a woman on long-term bisphosphonate therapy (Osteoporos Int)
11/18/2015 A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates (Osteoporos Int)
10/30/2015 FRAX and fracture prediction without bone mineral density (Climacteric)
10/26/2015 Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study (Osteoporos Int)
10/20/2015 Treatment of osteoporosis after alendronate or risedronate (Osteoporos Int)
09/09/2015 S3 guideline. Part 2: Non-Traumatic Avascular Femoral Head Necrosis in Adults - Untreated Course and Conservative Treatment (Z Orthop Unfall)
08/14/2015 Recovery of Severe Muscular and Fascial Calcinosis After Treatment With Bisphosphonates in a Child With Juvenile Dermatomyositis (JCR, Journal of Clinical Rheumatology)
08/06/2015 Vitamin D, osteoprotegerin/receptor activator of nuclear factor-kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV-infected patients with reduced bone mineral density (HIV Med)
07/28/2015 Effects of teriparatide retreatment in a patient with ?-thalassemia major (Transfusion)
07/10/2015 Mapping Bone Changes at the Proximal Femoral Cortex of Postmenopausal Women in Response to Alendronate and Teriparatide Alone, Combined or Sequentially (J Bone Miner Res)
05/04/2015 Comparative Resistance to Teriparatide-Induced Bone Resorption with Denosumab or Alendronate (J Clin Endocrinol Metab)
03/30/2015 Patient preference for monthly bisphosphonate versus weekly bisphosphonate in a cluster-randomized, open-label, crossover trial: Minodroate Alendronate/Risedronate Trial in Osteoporosis (MARTO) (J Bone Miner Metab)
03/27/2015 Pharmacological interventions for pain in children and adolescents with life-limiting conditions (Cochrane Database Syst Rev)


 1  2  3  4     Next


Copyright © 2016, NTK Institute |  Terms and Conditions  |  Privacy Policy